BANK VONTOBEL/PUT/NOVO NORDISK ADR B/100/0.1/20.12.24 Share Price

Warrant

DE000VM7SKE6

Market Closed - Deutsche Boerse AG 18:45:16 05/07/2024 BST
0.101 EUR -19.20% Intraday chart for BANK VONTOBEL/PUT/NOVO NORDISK ADR B/100/0.1/20.12.24
Current month+31.17%
1 month-7.34%
Date Price Change
05/07/24 0.101 -19.20%
04/07/24 0.125 -8.76%
03/07/24 0.137 +50.55%
02/07/24 0.091 +37.88%
01/07/24 0.066 -14.29%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 06:45 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VM7SKE
ISINDE000VM7SKE6
Date issued 02/01/2024
Strike 100 $
Maturity 20/12/2024 (167 Days)
Parity 10 : 1
Emission price 0.9
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.99
Lowest since issue 0.066
Delta-0.06x
Omega 7.731
Premium30.58x
Gearing122.74x
Moneyness 0.7024
Difference Strike -42.37 $
Difference Strike %-42.37%
Spread 0.01
Spread %8.93%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus